Publications by authors named "Hisashi Higuchi"

Claim this Profile
B
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.
Hitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Kazuyuki Inoue

Neuropsychobiology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probable aripiprazole-induced tardive writer's cramp.
Kazuhiro Sato, Keizo Yoshida, Hisashi Higuchi

J Neuropsychiatry Clin Neurosci· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder.
Mitsuhiro Kamata, Akihito Suzuki, Keizo Yoshida, Hitoshi Takahashi, Hisashi Higuchi

J Affect Disord· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression.
Keiichiro Tominaga, Mioto Okazaki, Hisashi Higuchi, Itaru Utagawa, Etsuko Nakamura

Int J Gen Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients.
Hisashi Higuchi, Kazuhiro Sato, Shingo Naito, Keizo Yoshida, Hitoshi Takahashi

Neuropsychiatr Dis Treat· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.
Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida

Neuropsychiatr Dis Treat· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
Mioto Okazaki, Keiichiro Tominaga, Hisashi Higuchi, Itaru Utagawa, Etsuko Nakamura

J ECT· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Hisashi Higuchi

Nihon Shinkei Seishin Yakurigaku Zasshi· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of milnacipran in the treatment of chronic pain syndromes.
Mitsuhiro Kamata, Shingo Naito, Hisashi Higuchi, Akihito Suzuki, Koichi Otani

Int J Psychiatry Clin Pract· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of phantom limb pain and sensation with milnacipran.
Kazuhiro Sato, Hisashi Higuchi, Yasuo Hishikawa

J Neuropsychiatry Clin Neurosci· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
Hisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi, Mitsuhiro Kamata

Psychiatry Clin Neurosci· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case series.
Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, Hisashi Higuchi, Jun Ishigooka

Hum Psychopharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders.
Hisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi, Mitsuhiro Kamata

Psychiatry Clin Neurosci· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran.
Keizo Yoshida, Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Kazuhiro Sato

Hum Psychopharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population.
Kazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata

Biol Pharm Bull· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.
Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Hitoshi Takahashi, Kazuyuki Inoue

J Psychopharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.
Shingo Naito, Kazuhiro Sato, Keizo Yoshida, Hisashi Higuchi, Hitoshi Takahashi

Psychiatry Clin Neurosci· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, Jun Ishigooka, Hisashi Higuchi

J Clin Psychiatry· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial.
Hitoshi Takahashi, Keizo Yoshida, Jun Ishigooka, Hisashi Higuchi

Prog Neuropsychopharmacol Biol Psychiatry· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patients.
Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Hitoshi Takahashi, Mitsuhiro Kamata

Clin Neuropharmacol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.
Hisashi Higuchi, Mitsuhiro Kamata, Yuka Sugawara, Keizo Yoshida

Clin Neuropharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.
Tadao Arinami, Tsuyuka Ohtsuki, Hiroki Ishiguro, Hiroshi Ujike, Yuji Tanaka, Tomo Hashiguchi, Hisashi Higuchi

Am J Hum Genet· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked effect of milnacipran combined with olanzapine for a delusional depressive patient.
Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Tetsuo Shimizu

Neuropsychiatr Dis Treat· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-factor model of the MADRS in major depressive disorder.
Akihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, Keizo Yoshida, Hisashi Higuchi

Depress Anxiety· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis